{"title":"长链非编码RNA MALAT1与肿瘤转移","authors":"Jongchan Kim","doi":"10.21037/BIOTARGET.2019.04.02","DOIUrl":null,"url":null,"abstract":"Since Malat1 was identified as a prognostic marker for poor clinical outcomes in non-small cell lung cancer (NSCLC) patients, number of Malat1 studies have revealed its roles in human cancers (1,2). Recently, we demonstrated unexpected Malat1 Malat1</em studies conducted by ourselves and others by comparing research designs and interpreting the results.","PeriodicalId":92338,"journal":{"name":"Biotarget","volume":" ","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2019-05-05","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.21037/BIOTARGET.2019.04.02","citationCount":"1","resultStr":"{\"title\":\"Long noncoding RNA MALAT1 and cancer metastasis\",\"authors\":\"Jongchan Kim\",\"doi\":\"10.21037/BIOTARGET.2019.04.02\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"Since Malat1 was identified as a prognostic marker for poor clinical outcomes in non-small cell lung cancer (NSCLC) patients, number of Malat1 studies have revealed its roles in human cancers (1,2). Recently, we demonstrated unexpected Malat1 Malat1</em studies conducted by ourselves and others by comparing research designs and interpreting the results.\",\"PeriodicalId\":92338,\"journal\":{\"name\":\"Biotarget\",\"volume\":\" \",\"pages\":\"\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2019-05-05\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://sci-hub-pdf.com/10.21037/BIOTARGET.2019.04.02\",\"citationCount\":\"1\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Biotarget\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.21037/BIOTARGET.2019.04.02\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Biotarget","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.21037/BIOTARGET.2019.04.02","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
Since Malat1 was identified as a prognostic marker for poor clinical outcomes in non-small cell lung cancer (NSCLC) patients, number of Malat1 studies have revealed its roles in human cancers (1,2). Recently, we demonstrated unexpected Malat1 Malat1